Bank of New York Mellon’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $350M | Sell |
898,612
-45,619
| -5% | -$19.3M | 0.06% | 285 |
|
|
2026
Q1 | $447M | Sell |
944,231
-25,736
| -3% | -$13M | 0.08% | 225 |
|
|
2025
Q4 | $453M | Sell |
969,967
-156,716
| -14% | -$72.8M | 0.08% | 212 |
|
|
2025
Q3 | $480M | Sell |
1,126,683
-23,154
| -2% | -$8.97M | 0.09% | 205 |
|
|
2025
Q2 | $441M | Sell |
1,149,837
-108,047
| -9% | -$38.9M | 0.08% | 212 |
|
|
2025
Q1 | $435M | Sell |
1,257,884
-25,484
| -2% | -$8.2M | 0.09% | 217 |
|
|
2024
Q4 | $385M | Sell |
1,283,368
-26,584
| -2% | -$9.29M | 0.07% | 244 |
|
|
2024
Q3 | $532M | Sell |
1,309,952
-89,402
| -6% | -$32.7M | 0.1% | 195 |
|
|
2024
Q2 | $450M | Sell |
1,399,354
-58,226
| -4% | -$18.9M | 0.09% | 214 |
|
|
2024
Q1 | $486M | Sell |
1,457,580
-15,929
| -1% | -$4.87M | 0.09% | 201 |
|
|
2023
Q4 | $399M | Sell |
1,473,509
-74,401
| -5% | -$18.4M | 0.08% | 228 |
|
|
2023
Q3 | $381M | Sell |
1,547,910
-64,031
| -4% | -$17.5M | 0.08% | 208 |
|
|
2023
Q2 | $489M | Sell |
1,611,941
-76,414
| -5% | -$21.2M | 0.1% | 182 |
|
|
2023
Q1 | $445M | Sell |
1,688,355
-60,375
| -3% | -$15.3M | 0.1% | 190 |
|
|
2022
Q4 | $420M | Sell |
1,748,730
-139,622
| -7% | -$31.3M | 0.1% | 204 |
|
|
2022
Q3 | $347M | Sell |
1,888,352
-158,146
| -8% | -$31.5M | 0.08% | 217 |
|
|
2022
Q2 | $344M | Sell |
2,046,498
-180,585
| -8% | -$38.8M | 0.08% | 224 |
|
|
2022
Q1 | $558M | Sell |
2,227,083
-274,242
| -11% | -$68.9M | 0.11% | 172 |
|
|
2021
Q4 | $643M | Buy |
2,501,325
+39,701
| +2% | +$9.71M | 0.12% | 155 |
|
|
2021
Q3 | $597M | Sell |
2,461,624
-131,523
| -5% | -$32.2M | 0.12% | 155 |
|
|
2021
Q2 | $536M | Sell |
2,593,147
-374,952
| -13% | -$76.4M | 0.1% | 171 |
|
|
2021
Q1 | $559M | Buy |
2,968,099
+314,801
| +12% | +$55.5M | 0.11% | 161 |
|
|
2020
Q4 | $436M | Buy |
2,653,298
+263,446
| +11% | +$38.5M | 0.09% | 179 |
|
|
2020
Q3 | $298M | Buy |
2,389,852
+391,768
| +20% | +$48.5M | 0.07% | 224 |
|
|
2020
Q2 | $194M | Buy |
1,998,084
+10,415
| +0.5% | +$1.08M | 0.05% | 321 |
|
|
2020
Q1 | $179M | Sell |
1,987,669
-29,586
| -1% | -$3.83M | 0.06% | 288 |
|
|
2019
Q4 | $298M | Buy |
2,017,255
+82,433
| +4% | +$11.1M | 0.08% | 240 |
|
|
2019
Q3 | $233M | Sell |
1,934,822
-77,499
| -4% | -$10M | 0.06% | 286 |
|
|
2019
Q2 | $272M | Sell |
2,012,321
-461,416
| -19% | -$58.3M | 0.07% | 249 |
|
|
2019
Q1 | $323M | Buy |
2,473,737
+133,386
| +6% | +$17.9M | 0.09% | 200 |
|
|
2018
Q4 | $291M | Sell |
2,340,351
-66,458
| -3% | -$8.92M | 0.09% | 204 |
|
|
2018
Q3 | $335M | Buy |
2,406,809
+324,724
| +16% | +$40.4M | 0.09% | 219 |
|
|
2018
Q2 | $214M | Sell |
2,082,085
-50,881
| -2% | -$5.15M | 0.06% | 323 |
|
|
2018
Q1 | $207M | Sell |
2,132,966
-128,094
| -6% | -$12.4M | 0.06% | 333 |
|
|
2017
Q4 | $199M | Sell |
2,261,060
-36,537
| -2% | -$2.94M | 0.05% | 373 |
|
|
2017
Q3 | $183M | Sell |
2,297,597
-33,132
| -1% | -$2.66M | 0.05% | 373 |
|
|
2017
Q2 | $203M | Sell |
2,330,729
-190,265
| -8% | -$16.1M | 0.06% | 344 |
|
|
2017
Q1 | $224M | Sell |
2,520,994
-59,162
| -2% | -$4.93M | 0.06% | 329 |
|
|
2016
Q4 | $191M | Sell |
2,580,156
-249,827
| -9% | -$18.7M | 0.06% | 358 |
|
|
2016
Q3 | $214M | Buy |
2,829,983
+8,913
| +0.3% | +$682K | 0.06% | 320 |
|
|
2016
Q2 | $217M | Sell |
2,821,070
-151,138
| -5% | -$11.9M | 0.07% | 307 |
|
|
2016
Q1 | $232M | Sell |
2,972,208
-116,525
| -4% | -$8.14M | 0.07% | 290 |
|
|
2015
Q4 | $209M | Sell |
3,088,733
-213,976
| -6% | -$14.9M | 0.06% | 310 |
|
|
2015
Q3 | $255M | Buy |
3,302,709
+45,146
| +1% | +$4M | 0.08% | 263 |
|
|
2015
Q2 | $296M | Sell |
3,257,563
-504,239
| -13% | -$40.4M | 0.08% | 261 |
|
|
2015
Q1 | $283M | Buy |
3,761,802
+1,356,084
| +56% | +$97.4M | 0.07% | 303 |
|
|
2014
Q4 | $177M | Sell |
2,405,718
-986,650
| -29% | -$69.3M | 0.05% | 400 |
|
|
2014
Q3 | $239M | Sell |
3,392,368
-92,789
| -3% | -$6.13M | 0.06% | 307 |
|
|
2014
Q2 | $196M | Buy |
3,485,157
+2,072,415
| +147% | +$109M | 0.05% | 365 |
|
|
2014
Q1 | $74.2M | Buy |
1,412,742
+10,301
| +0.7% | +$513K | 0.02% | 694 |
|
|
2013
Q4 | $66.9M | Sell |
1,402,441
-1,136,406
| -45% | -$52.5M | 0.02% | 727 |
|
|
2013
Q3 | $109M | Sell |
2,538,847
-275,528
| -10% | -$10.8M | 0.03% | 520 |
|
|
2013
Q2 | $101M | Buy |
+2,814,375
| New | +$109M | 0.03% | 520 |
|
Other funds holding HCA
CAM
MC
Bank of New York Mellon's HCA Position: Q2 2026 in Review
Bank of New York Mellon reduced its HCA Healthcare (HCA) stake by 4.8% in Q2 2026, selling an estimated $19.3M and leaving 898,612 shares worth $350M. The position accounts for 0.06% of the portfolio, ranked #285.
Bank of New York Mellon first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $643M in Q4 2021. 911 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Bank of New York Mellon held 898,612 shares of HCA Healthcare worth $350M as of Q2 2026.
- Bank of New York Mellon sold 45,619 HCA Healthcare shares in Q2 2026, an estimated $19.3M.
- HCA Healthcare made up 0.06% of Bank of New York Mellon's portfolio in Q2 2026, its #285 holding.
- Bank of New York Mellon first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's HCA Healthcare position peaked at $643M in Q4 2021.
- 911 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.